Clinical Trial Highlights

• Apixaban Superior to Warfarin in Patients with Atrial Fibrillation as well as Prior Stroke or TIA
• No Compelling Evidence to Use Warfarin or Aspirin in HF Patients
• AXIS 2 Clinical Outcomes No Different than Placebo
• SAMMPRIS: 30-Day Outcomes after Angioplasty and Stenting
• AMM Benefits Those Who Fail Antithrombotic Therapy
• Initial Clinical Results with TREVO® Mechanical Thrombectomy Device are Promising
• Linking sICH Definitions to Outcomes
• Solitaire™ FR Device Achieves Successful Recanalization Almost Free of Symptomatic Hemorrhage Transformation
• FIA II Seeks Genetic Underpinnings of Familial Intracranial Aneurysm
• SPS3 Study Does Not Support the Use of Combination Therapy for Stroke Prevention
• Novel Agent NA-1 Proves That Ischemic Neuroprotection is Possible in Older Patients